Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Woods, Mandy ^a   Bishop Bailey, David ^b   Pepper, John R ^c   Evans, Timothy W ^c   Mitchell, Jane A ^c   Warner, Timothy D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Endothelin 1; Lipopolysaccharide; Vascular smooth muscle

Indexed keywords

CYTOKINE; ENDOTHELIN 1; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; LIPOPOLYSACCHARIDE;

ARTICLE; CELL CULTURE; DRUG EFFECT; FEMALE; HUMAN; MAMMARY ARTERY; METABOLISM; POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; STIMULATION; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; CYTOKINES; ENDOTHELIN-1; ENDOTOXINS; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; STIMULATION, CHEMICAL;

EID: 0031644535     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00097     Document Type: Article

References (15)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2864-7.
3. Kanse SM, Takahashi K, Warren JB, et al. Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol 1991;17(suppl 7):S113-6.
4. Yu JCM, Davenport AP. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol 1995;114:551-7.
5. Warner TD, Battistini B, Doherty AM, Corder R. Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 1994;48:625-35.
6. Warner TD. Characterisation of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications. Eur Heart J 1993;14(suppl 1):42-7.
7. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease. Clin Sci 1993; 84:485-500.
8. Muggins JP, Pelton JT, Miller RC. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 1993;59:55-123.
9. Klemm P, Warner TD, Hohfeld T, Corder R, Vane JR. Endothelin-1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci USA 1995; 92:2691-5.
10. Russell R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 1971;50:172-86.
11. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
12. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature 1980;288:373-6.
13. Palmer RMJ, Ferrige AJ, Monacada S. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 1988;333:664-6.
14. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-5.
15. Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 1994;344: 1405-6.